Bull Pharmachem
Bull Pharmachem
Kalbadevi, Mumbai, Maharashtra
GST No. 27AKFPJ6383E1Z2
TrustSEAL Verified
Call 0804897311978% Response Rate
SEND EMAIL

Pharmaceutical Injection

Prominent & Leading Exporter from Mumbai, we offer beovu brolucizumab dbll 6mg injection, nebido testosterone undecanoate injection, adalimumab 40mg, tecentriq atezolizumab 1200mg, secukinumab 150mg/ml powder for solution for injection and dexmethasone injection.

Beovu Brolucizumab Dbll 6mg Injection

Beovu Brolucizumab Dbll 6mg Injection
  • Beovu Brolucizumab Dbll 6mg Injection
Ask For Price
Product Price :Get Latest Price
Product Brochure

Product Details:

Packaging TypeVial
Packaging Size1 x 2 ml Vial, 1 x Filter Needle
BrandBeovu
Dose6mg/0.05ml
Usage/ApplicationNeovascular
Dose/Strength6mg
Manufactured ByNovartis

BEOVU (brolucizumab-dbll 6mg) injection is used for the treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD). Important Safety Information Contraindications Beovu is contraindicated in patients with ocular or periocular infections, active intraocular inflammation or known hypersensitivity to brolucizumab or any of the excipients in BEOVU. Hypersensitivity reactions may manifest as rash, pruritus, urticaria, erythema, or severe intraocular inflammation. WARNINGS AND PRECAUTIONS Endophthalmitis and Retinal Detachment Intravitreal injections, including those with BEOVU, have been associated with endophthalmitis and retinal detachment. Proper aseptic injection techniques must always be used when administering BEOVU. Patients should be instructed to report any symptoms suggestive of endophthalmitis or retinal detachment without delay and should be managed appropriately. Retinal Vasculitis and/or Retinal Vascular Occlusion Retinal vasculitis and/or retinal vascular occlusion, typically in the presence of intraocular inflammation, have been reported with the use of BEOVU. Patients should be instructed to report any change in vision without delay. Increase in Intraocular Pressure Acute increases in intraocular pressure (IOP) have been seen within 30 minutes of intravitreal injection including with BEOVU. Sustained IOP increases have also been reported. Both IOP and perfusion of the optic nerve head must be monitored and managed appropriately. Thromboembolic Events Although there was a low rate of arterial thromboembolic events (ATEs) observed in the BEOVU clinical trials, there is a potential risk of ATEs following intravitreal use of VEGF inhibitors. Arterial thromboembolic events are defined as nonfatal stroke, nonfatal myocardial infarction, or vascular death (including deaths of unknown cause). The ATE rate in the two controlled 96-week neovascular AMD studies (HAWK and HARRIER) during the first 96-weeks was 4.5% (33 of 730) in the pooled brolucizumab arms compared with 4.7% (34 of 729) in the pooled aflibercept arms. ADVERSE REACTIONS Serious adverse reactions including endophthalmitis, retinal detachment, retinal vasculitis and/or retinal vascular occlusion, increases in intraocular pressure, and arterial thromboembolic events have occurred following intravitreal injections with BEOVU. The most common adverse events (≥5% of patients) with BEOVU were vision blurred, cataract, conjunctival hemorrhage, vitreous floaters and eye pain. As with all therapeutic proteins, there is a potential for an immune response in patients treated with BEOVU. Anti-brolucizumab antibodies were detected in the pre-treatment sample of 36% to 52% of treatment naive patients. After initiation of dosing, anti-brolucizumab antibodies were detected in at least one serum sample in 53% to 67% of patients treated with BEOVU. Intraocular inflammation was observed in 6% of patients with anti-brolucizumab antibodies detected during dosing with BEOVU. The significance of anti-brolucizumab antibodies on the clinical effectiveness and safety of BEOVU is not known.
Request
Callback
Yes! I am Interested

Nebido Testosterone Undecanoate Injection

Nebido Testosterone Undecanoate Injection
  • Nebido Testosterone Undecanoate Injection
Ask For Price
Product Price :Get Latest Price
Product Brochure

Product Details:

Brand NameNebido
ManufacturerBayer
Packaging TypeBottle
Packaging Size1 Vial
Dose1000 Mg
Shelf Life2 Years
Storage Temperature30 Degree C
TreatmentMale Hypogonadism.

Nebido is a testosterone preparation for intramuscular injection. One ampoule contains 1,000 mg testosterone undecanoate in 4 mL oily vehicle (castor oil). The shelf life of Nebido is 5 years. Nebido is the first long-acting testosterone injection for the treatment of male hypogonadism. Nebido contains 1,000 mg of testosterone undecanoate in a 4 mL oily solution in an innovative formulation which offers a superior kinetic profile. After administration of Nebido, testosterone levels remain within the physiological range for about 12 weeks. Therefore, only 4 injections per year are required in long-term testosterone therapy. Nebido avoids unphysiological peaks and troughs in serum testosterone. It has been established in clinical studies that testosterone levels are already back to the normal range 3 days after the first administration of Nebido. On testosterone concentrations in the blood Pharmacokinetic studies have demonstrated that testosterone levels are restored to the physiological range within 3 days after the first administration of Nebido. With an interval between injections of about 12 weeks, testosterone concentrations remain constantly within the physiological range. The first dosing interval may be reduced to six weeks, which enables steady state testosterone levels to be achieved more rapidly. On clinical symptoms Nebido improves the symptoms associated with testosterone deficiency. Nebido exerts a positive effect on sexual function and mood, increases muscle mass and muscle strength and decreases body fat. The most frequent side effects observed with Nebido are reactions at the injection site. These reactions are generally mild and transient. All other side effects observed in isolated cases are typical of testosterone (such as diarrhoea, joint pain, sweating, headache, acne, chest pain and gynaecomastia). Pulmonary oil microembolism has been observed after injection during routine clinical practice and in rare cases lead to signs and symptoms such as cough, dyspnea, malaise, hyperhidrosis, chest pain, dizziness, paraesthesia, or syncope. These reactions may occur during or immediately after the injection and are reversible. The patient should therefore be observed during and immediately after each injection in order to allow for early recognition of possible signs and symptoms of pulmonary oily microembolism. Treatment is usually supportive, e.g. by administration of supplemental oxygen. Attention should be paid to the following recommendations for dosage: First and second administration of Nebido 6 weeks apart. Subsequently, depending on the needs of the individual patient, an interval of about 12 weeks is recommended. The first interval between injections may also be shortened to six weeks for patients who have switched from other testosterone preparations to Nebido, under observation of clinical symptoms. Ideally one ampoule of Nebido is injected deeply into the gluteal muscle slowly over a period of approximately 2 minutes. Measurement of serum trough testosterone levels and clinical symptoms should be considered for individualization of therapy with Nebido. Serum trough testosterone levels should be in the lower third of the normal range. Since steady state serum testosterone levels can be assumed to be achieved after the first six months of treatment, it appears advisable to control serum testosterone before the fourth injection (usual spacing between administrations provided).
Request
Callback


Additional Information:

  • Production Capacity: NA
  • Packaging Details: "Trademark shown are property of their respective owners and we do not lay any claim on them. Parallel trade if any is conducted under WTO¿¿¿s TRIPS agreement to which India is a Signatory. On this page we have made an ¿¿¿Honest Reference¿¿¿ of this product under the Trademark Act of India and applicable rules in the Territory of India. We do not claim ownership of displayed Trade mark."
Yes! I am Interested

Adalimumab 40MG

Adalimumab 40MG
  • Adalimumab 40MG
  • Adalimumab 40MG
  • Adalimumab 40MG
Get Best Quote
Approx. Price: Rs 10,000 / boxGet Latest Price
Product Brochure

Product Details:

BrandMabura
ManufacturerHetero Healthcare
Strength / Dose40 mg / 0.8 ml
Packaging TypePre Filled Syringe
CompositionAdalimumab
UsageRheumatoid arthritis
Prescription/Non-PrescriptionPrescription

Adalimumab, sold under the brand name Humira, among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis.Use is generally only recommended in people who have not responded to other treatments. It is administered by injection under the skin.
Request
Callback
Yes! I am Interested

Tecentriq Atezolizumab 1200mg

Tecentriq Atezolizumab 1200mg
  • Tecentriq Atezolizumab 1200mg
Ask For Price
Product Price :Get Latest Price
Product Brochure

Product Details:

Packaging Size1 Vial of 20ml
ManufacturerRoche Ltd
BrandTecentriq
CompositionAtezolizumab
PackagingBottle
TreatmentUrothelial carcinoma
Dosage FormVial
Prescription/Non prescriptionPrescription
Storage8 Degree C

TECENTRIQ (Atezolizumab 1200mg) is a prescription medicine used to treat adults with: A type of bladder and urinary tract cancer called urothelial carcinoma. What is the most important information about TECENTRIQ? TECENTRIQ can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become severe or life-threatening and can lead to death. You can have more than one of these problems at the same time. These problems may happen anytime during your treatment or even after your treatment has ended. Call or see your healthcare provider right away if you develop any new or worse signs or symptoms, including: Lung problems cough shortness of breath chest pain Intestinal problems diarrhea (loose stools) or more frequent bowel movements than usual stools that are black, tarry, sticky, or have blood or mucus severe stomach-area (abdomen) pain or tenderness Liver problems yellowing of your skin or the whites of your eyes severe nausea or vomiting pain on the right side of your stomach area (abdomen) dark urine (tea colored) bleeding or bruising more easily than normal Hormone gland problems headaches that will not go away or unusual headaches eye sensitivity to light eye problems rapid heartbeat increased sweating extreme tiredness weight gain or weight loss feeling more hungry or thirsty than usual urinating more often than usual hair loss feeling cold constipation your voice gets deeper dizziness or fainting changes in mood or behavior, such as decreased sex drive, irritability, or forgetfulness Kidney problems decrease in your amount of urine blood in your urine swelling of your ankles loss of appetite Skin problems rash itching skin blistering or peeling painful sores or ulcers in mouth or nose, throat, or genital area fever or flu-like symptoms swollen lymph nodes Problems can also happen in other organs. These are not all of the signs and symptoms of immune system problems that can happen with TECENTRIQ. Call or see your healthcare provider right away for any new or worse signs or symptoms, including: Chest pain, irregular heartbeat, shortness of breath, or swelling of ankles Confusion, sleepiness, memory problems, changes in mood or behavior, stiff neck, balance problems, tingling or numbness of the arms or legs Double vision, blurry vision, sensitivity to light, eye pain, changes in eyesight Persistent or severe muscle pain or weakness, muscle cramps Low red blood cells, bruising Infusion reactions that can sometimes be severe or life-threatening. Signs and symptoms of infusion reactions may include: chills or shaking itching or rash flushing shortness of breath or wheezing dizziness feeling like passing out fever back or neck pain Complications, including graft-versus-host disease (GVHD), in people who have received a bone marrow (stem cell) transplant that uses donor stem cells (allogeneic). These complications can be serious and can lead to death. These complications may happen if you underwent transplantation either before or after being treated with TECENTRIQ. Your healthcare provider will monitor you for these complications. Getting medical treatment right away may help keep these problems from becoming more serious. Your healthcare provider will check you for these problems during your treatment with TECENTRIQ. Your healthcare provider may treat you with corticosteroid or hormone replacement medicines. Your healthcare provider may also need to delay or completely stop treatment with TECENTRIQ if you have severe side effects.
Request
Callback


Additional Information:

  • Production Capacity: NA
  • Delivery Time: Immediate
  • Packaging Details: Trademark shown are property of their respective owners and we do not lay any claim on them. Parallel trade if any is conducted under WTO¿¿¿s TRIPS agreement to which India is a Signatory. On this page we have made an ¿¿¿Honest Reference¿¿¿ of this product under the Trademark Act of India and applicable rules in the Territory of India. We do not claim ownership of displayed Trade mark.
Yes! I am Interested

Secukinumab 150mg/Ml Powder For Solution For Injection

Secukinumab 150mg/Ml Powder For Solution For Injection
  • Secukinumab 150mg/Ml Powder For Solution For Injection
Ask For Price
Product Price :Get Latest Price
Product Brochure

Product Details:

ManufacturerNovartis Healthcare Pvt. Ltd
Dose150 Mg
Packaging TypeBottle
BrandScapho
CompositionSecukinumab 150 Mg
Packaging Size1 Vial

SCAPHO (Secukinumab 150 Mg) Injection is an interleukin inhibitor used for the treatment of moderate to severe plaque psoriasis (a skin disease characterized by red, scaly patches on some areas of the body) in adults patients, where the systemic therapy is appropriate. It is also used to treat active psoriatic arthritis and active ankylosing spondylitis in adults. This medicine is not recommended for use in patients below 18 years of age.DosageMissed DoseSince this medicine is administered by a qualified healthcare professional in the clinical or hospital setting, the likelihood of a missed dose is very low. If you miss an appointment for a scheduled dose of this medicine, contact your doctor immediately for further instructions.OverdoseSince this medicine is administered in the hospital or clinical setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
Side effectsMajor & minor side effects for Scapho InjectionHeadacheMuscle painFeverChillsCoughUnusual tiredness or weaknessRunny NoseSore throatEar congestionItching or skin rashFast heartbeatSevere stomach painDizziness
This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Inform the doctor if you have a known history of allergy to this medicine. Report to the doctor all your current medicines including any herbs and supplements as well as your medical conditions before receiving this medicine. Consult your doctor immediately if you develop any signs and symptoms of an infection.
Request
Callback
Yes! I am Interested

Dexmethasone Injection

Dexmethasone Injection
  • Dexmethasone Injection
Ask For Price
Product Price :Get Latest Price

Product Details:

BrandDexona
ManufacturerZydus
Strength4mg
Packaging TypeAmpoules
Packaging Size2ml
Usage/ApplicationRheumatic problems, Gastrointestinal disease, Treat severe allergic, Mild Covid 19

Dexamethasone Injection is used to treat inflammation of the skin, joints, lungs, and other organs. Also Common conditions treated include asthma, allergies, and arthritis.td {border: 1px solid #ccc;}br {mso-data-placement:same-cell;}
Request
Callback
Yes! I am Interested
X

Explore More Product

View All Product


Reviews & Rating

4.9/5

★★★★★★★★★★

Reviewed by 366 Users

  • 5★81%
  • 4★8%
  • 3★3%
  • 2★1%
  • 1★7%
  • User Satisfaction
  • Response94%
  • Quality     96%
  • Delivery   95%

Most Relevant Reviews

K
★★★★★★★★★★
26-October-21
Kathy Zeigler
United States Of America
Product Name : Ivermectin Tablets
Very prompt in responding to my questions, answered all my questions. Took about 3 weeks to receive from India to the USA; which they sent me the tracking and overall it was a great experience.
Response
Quality
Delivery
reviewImg1
D
★★★★★★★★★★
06-September-21
David Cowley
United States Of America
Product Name : Ledifos
Response time was very fast and the customer service excellent.The goods arrived on time and were reasonably priced.I can highly recommend Bull Pharmachem
Response
Quality
Delivery
reviewImg1
L
★★★★★★★★★★
01-September-22
Lynda Dowling
Australia
Product Name : Ivermectin Tablets
Good communication Product arrived in perfect condition
Response
Quality
Delivery

View More Reviews




Reach Us
Rakshit Jain (Sales & Marketing Manager)
Bull Pharmachem
No. 64C, Dhan Sadan Co Operative Housing Society, 2nd Floor
Kalbadevi, Mumbai - 400002, Maharashtra, India


Call Us


Send E-mail